In an open letter published in the New York Times, former CDC directors call on Congress to mitigate threats to public health caused by mass layoffs and cuts to critical programs. 

Hypertension is a significant issue in Japan, impacting an estimated 43 million adults. Medtronic's Symplicity Spyral RDN system is now approved for the treatment of those patients. 

Despite its high accuracy, CTA can come with tradeoffs including requiring radiologists to review a high number of images looking for findings that can be subtle, increasing case complexity and workloads. 

Umar Mahmood, MD, PhD, currently is chief of nuclear medicine and molecular imaging at Massachusetts General Hospital and a Harvard professor of radiology, will take on the title beginning Feb. 1. 

Marcy Markes, NP, has secured representation from the Pacific Legal Foundation in an effort to overturn a state law that requires nurse practitioners to pay a physician “collaborator” if they wish to run their own practice. The lawsuit argues the regulation exists only to stifle competition.

The pharmacy chain also agreed to perform an annual audit of billed drug prices to ensure it does not run afoul of the state’s “Most Favored Nation” policy. 

The Class 2 recall pertains to the system's built-in shielding and collimation accessories. 

Recor Medical's Paradise Ultrasound Renal Denervation System is the first medical device approved for the treatment of hypertension in Japan. It first gained FDA approval back in 2023.